Punjab: 50-year-old pharmacist harassed, blackmailed, extorted of Rs 6 lakh; constable held Medical Dialogues Bureau25 Dec 2019 12:00 PM ISTPunjab: A city-based pharmacist became a victim of extortion from none other than a police constable, who was recently arrested for taking Rs 6 lakh...
Alembic Pharma glaucoma drug Travoprost Ophthalmic Solution gets USFDA approval Medical Dialogues Bureau25 Dec 2019 9:55 AM ISTThe USFDA approved Travoprost Ophthalmic Solution is a generic equivalent to Alcon Pharmaceuticals' Travatan Ophthalmic Solution, Alembic...
Granules India gets USFDA nod for allergy treatment drug Loratadine Medical Dialogues Bureau25 Dec 2019 9:50 AM IST"The US Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules India Ltd, for Loratadine...
Roche to pay USD 1.15 billion to Sarepta for gene therapy licensing deal Medical Dialogues Bureau25 Dec 2019 9:32 AM ISTRoche will make an upfront payment of $750 million in cash and take a $400 million stake in Sarepta, priced at $158.59 per share, a premium of about...
Merck KEYTRUDA gets Japanese nod for head, neck cancer Medical Dialogues Bureau25 Dec 2019 9:30 AM ISTNew Delhi: Merck, known as MSD outside the United States and Canada, recently announced that KEYTRUDA, Merck’s anti-PD-1 therapy, received new...
Sunovion Pharma resubmits application to USFDA for sublingual Apomorphine to treat Parkinsons disease Farhat Nasim25 Dec 2019 9:15 AM ISTNew Delhi: Sunovion Pharmaceuticals Inc. (Sunovion) recently announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug...
Sick, loss-making Hindustan Antibiotics up for sale: Minister Medical Dialogues Bureau24 Dec 2019 6:00 PM ISTNew Delhi: Loss making Hindustan Antibiotics Limited (HAL) is going to be sold off based on the recommendations of a Committee of Ministers.The...
Glenmark, Mankind Pharma ink licensing pact to co-market diabetes drug Remogliflozin Medical Dialogues Bureau24 Dec 2019 12:05 PM ISTUnder the sub-licensing agreement, Mankind will market diabetes drug Remogliflozin Etabonate under its own trademark while Glenmark will manufacture...
FIRST: Mylan, Micro Labs get USFDA nod for generic version of blood thinner Eliquis Medical Dialogues Bureau24 Dec 2019 9:45 AM ISTSales of Eliquis, which Bristol-Myers co-developed with Pfizer, rose 22% to $1.93 billion and made up about 30% of the Bristol-Myers' total revenues...
Allergan acute migraine drug Ubrelvy wins USFDA approval Medical Dialogues Bureau24 Dec 2019 9:30 AM ISTAllergan Plc's drug, Ubrelvy, is the first oral version of a new class of drugs called calcitonin gene-related peptide (CGRP) inhibitors to win the...
Merck Ebola vaccine Ervebo to be available at lowest access price for poor nations Medical Dialogues Bureau24 Dec 2019 9:00 AM ISTThe vaccine, Ervebo, was approved by the U.S. Food and Drug Administration on Thursday, a month after Europe gave its nod to the vaccine, a move that...
After Cipla, Glenmark Digihaler secures NPPA nod for separate price; Details Farhat Nasim23 Dec 2019 4:28 PM ISTNew Delhi: The National Pharmaceuticals Pricing Authority (NPPA) recently approved the price for the digital dose counter brand ’Digihaler’...
